Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which dressing is safer for ICU lines? new study compares gauze vs. clear patch

NCT ID NCT07437040

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested two ways of dressing central venous catheters in 78 intensive care patients: one using gauze and tape, the other using a clear, medicated patch. The goal was to see which method leads to fewer medical device-related pressure injuries at the insertion site. Researchers regularly checked the skin and used a standard risk scale to track any damage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one dressing type clearly causes fewer pressure injuries, it could guide hospitals to choose safer dressings for ICU patients with central lines.
What could go wrong
This is a small, single-center study (78 participants) that only looked at early-stage pressure injuries. Results may not apply to all ICU patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

78 people

The number who actually took part.

Started

Aug 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients hospitalized in the intensive care unit who: * Were aged 18 years or older, * Underwent a new central venous catheter insertion, * Had no pressure injury at the catheter insertion site at baseline, * Provided informed consent (patient or legal representative). Exclusion Criteria: Patients who: * Had a pressure injury at the catheter insertion site at baseline, * Had dermatological conditions affecting skin integrity at the catheter site, * Had a central venous catheter inserted at another institution, * Were discharged or deceased before completion of follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Medical device related pressure ulcer (mdrpu) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Prof. Dr. Cemil Taşçıoğlu City Hospital

    Istanbul, Istanbul, 34384, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.